SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-22-001659
Filing Date
2022-05-16
Accepted
2022-05-16 16:14:32
Documents
42
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q atxi-20220331x10q.htm   iXBRL 10-Q 805177
2 EX-31.1 atxi-20220331xex31d1.htm EX-31.1 12648
3 EX-31.2 atxi-20220331xex31d2.htm EX-31.2 11594
4 EX-32.1 atxi-20220331xex32d1.htm EX-32.1 6095
5 EX-32.2 atxi-20220331xex32d2.htm EX-32.2 6034
  Complete submission text file 0001410578-22-001659.txt   2470142

Data Files

Seq Description Document Type Size
6 EX-101.SCH atxi-20220331.xsd EX-101.SCH 20058
7 EX-101.CAL atxi-20220331_cal.xml EX-101.CAL 16203
8 EX-101.DEF atxi-20220331_def.xml EX-101.DEF 95725
9 EX-101.LAB atxi-20220331_lab.xml EX-101.LAB 142530
10 EX-101.PRE atxi-20220331_pre.xml EX-101.PRE 132022
36 EXTRACTED XBRL INSTANCE DOCUMENT atxi-20220331x10q_htm.xml XML 203576
Mailing Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014
Business Address 2 GANSEVOORT STREET 9TH FLOOR NEW YORK NY 10014 781-652-4500
AVENUE THERAPEUTICS, INC. (Filer) CIK: 0001644963 (see all company filings)

IRS No.: 474113275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38114 | Film No.: 22929180
SIC: 2834 Pharmaceutical Preparations